Fluicell
Gothenburg
About Fluicell
Fluicell AB is one of the manufacturers of fluid platforms for multifunctional pipettes. Living tissues are composed of a heterogeneous population of individual cells, which can differ dramatically from each other. These differences can have important consequences for the health and propagation of the entire population. To better study disease and aid in drug development, an in-depth analysis of cell behavior and physiological responses can best be accomplished with single-cell data. Our mission is to redefine the approach to cell biology, and drug discovery by providing miniaturized instrumentation for single-cell investigations. The company is a world leader and pioneer in open-volume microfluidics for the life sciences, and holds a strong IP and patent position with five different patent families in the estate. Fluicell counts to their roster some of the world´s most brilliant and influential scientists and innovators in the field. Our devices offer unprecedented data quality, throughput, resolution, and speed at affordable prices together with the capability to generate unique and critical data from single cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $470.4K
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2024)
- Ticker: fra:5J9
- Website: fluicell.com
- Phone: +46-762-08-33-54
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/fluicell-2242079 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.